AG00IJCR

956958-53-5 | N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide

Chemical structure of N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide, CAS 956958-53-5
AG00IJCR
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 956958-53-5
Catalog Number AG00IJCR(AGN-PC-0KA2AA)
Chemical Name N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide
IUPAC Name N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide
InChI InChI=1S/C21H16N6O2S2/c1-13-6-9-15(10-7-13)31(28,29)27-21-20(23-16-4-2-3-5-17(16)24-21)22-14-8-11-18-19(12-14)26-30-25-18/h2-12H,1H3,(H,22,23)(H,24,27)
InChI Key MQMKRQLTIWPEDM-UHFFFAOYSA-N
MDL Number MFCD16621245
Molecular Formula C21H16N6O2S2
Molecular Weight 448.5207
SMILES O=S(NC1=NC2=C(C=CC=C2)N=C1NC3=CC4=NSN=C4C=C3)(C5=CC=C(C=C5)C)=O
Synonyms
pilaralisib, SAR 245408, SAR245408, XL147, XL147, 956958-53-5, XL147 analogue, PI3K inhibitor X, XL 147, Pilaralisib analogue, N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide, N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide, CHEBI:71957, C21H16N6O2S2, N-(3-(benzo[c][1,2,5]thiadiazol-5-ylamino)quinoxalin-2-yl)-4-methylbenzenesulfonamide, Benzenesulfonamide, N-[3-(2,1,3-benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methyl-, 1033110-57-4, PubChem22457, XL-147 derivative 2, cc-43, AC1LZ6F0, AC1Q2LO8, Oprea1_361507, GTPL7963, SCHEMBL1792641, XL147-II, CHEMBL3218575, AOB5431, DTXSID10145779, SYN1127, HMS3654E06, BCP01861, EX-A1362, ZINC2267166, ABP000084, AN-530, MFCD16621245, s1118, STL325024, XL147 analogue(PI3K inhibitor X), XL147/XL-147, AKOS015842552, AKOS022131419, CS-0088, MCULE-9777093020, PB33271, QC-1903, RL06023, NCGC00346492-01, AC-23168, BC660050, HY-11105, SC-85909, AB0008192, FT-0662582, SW219812-1, X7417, EC-000.2364, J3.553.988C, A20590, Q-4583, N-[3-(2, J-519683, BRD-K95901403-001-01-1, N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxali, XL 147, XL-147, 956958-53-5, N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide,, N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methyl-benzenesulfonamide, N-[3-(2,1,3-benzothiadiazol-6-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide, SAR245408;N-(3-(benzo[c][1,2,5]thiadiazol-5-ylamino)quinoxalin-2-yl)-4-methylbenzenesulfonamide, XL-147|||N-[3-(2,1,3-Benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide, Pilaralisib, XL-147, SAR245408, D02IZS, D03KAC, ZSTK474, SAR-245408, RW3070, ZINC02267166, ACN-037797, CID1893730, A5112, SAR245408 + MSC1936369B, A10995, 934526-89-3,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited